3.25
                                            Schlusskurs vom Vortag:
              $3.25
            Offen:
              $3.25
            24-Stunden-Volumen:
                207.43K
            Relative Volume:
              0.91
            Marktkapitalisierung:
                $33.84M
            Einnahmen:
              $114.70K
            Nettoeinkommen (Verlust:
              $-37.06M
            KGV:
              -0.8139
            EPS:
                -3.9929
            Netto-Cashflow:
                $-30.69M
            1W Leistung:
              +7.26%
            1M Leistung:
              +57.77%
            6M Leistung:
                +103.12%
            1J Leistung:
              -16.24%
            Sab Biotherapeutics Inc Stock (SABS) Company Profile
Firmenname
                  
                      Sab Biotherapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      305-845-2813
                    
                Adresse
                  
                      777 W 41ST ST, MIAMI BEACH
                    
                Vergleichen Sie SABS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                SABS
                            
                             
                        Sab Biotherapeutics Inc 
                           | 
                    3.25 | 33.84M | 114.70K | -37.06M | -30.69M | -3.9929 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-09-17 | Eingeleitet | Leerink Partners | Outperform | 
| 2025-05-14 | Fortgesetzt | H.C. Wainwright | Buy | 
| 2024-10-09 | Eingeleitet | Craig Hallum | Buy | 
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform | 
| 2021-11-05 | Eingeleitet | Chardan Capital Markets | Buy | 
Sab Biotherapeutics Inc Aktie (SABS) Neueste Nachrichten
Will SAB Biotherapeutics Inc. stock deliver consistent dividendsJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - newser.com
Why SAB Biotherapeutics Inc. Equity Warrant stock is considered a top pickWeekly Trade Summary & Daily Chart Pattern Signals - newser.com
Can trapped investors hope for a rebound in SAB Biotherapeutics Inc. Equity WarrantStock Surge & Safe Swing Trade Setups - newser.com
Why SAB Biotherapeutics Inc. stock remains a top recommendation2025 Trading Volume Trends & Safe Entry Zone Tips - newser.com
What sentiment indicators say about SAB Biotherapeutics Inc. stockPortfolio Return Report & Verified Chart Pattern Trade Signals - newser.com
How SAB Biotherapeutics Inc. stock reacts to job market data2025 Trading Recap & Daily Profit Maximizing Tips - newser.com
Is SAB Biotherapeutics Inc. stock safe for conservative investors - newser.com
Using flow based indicators on SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
Will SAB Biotherapeutics Inc. stock deliver better than expected guidanceEarnings Recap Report & Accurate Technical Buy Alerts - newser.com
Reversal indicators forming on SAB Biotherapeutics Inc. stock2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Published on: 2025-11-03 08:31:25 - newser.com
What insider trading reveals about SAB Biotherapeutics Inc. Equity Warrant stockEarnings Recap Report & AI Driven Stock Price Forecasts - newser.com
Leading vs lagging indicators on SAB Biotherapeutics Inc. Equity Warrant performanceWeekly Risk Summary & AI Optimized Trading Strategy Guides - newser.com
Using Bollinger Bands to evaluate SAB Biotherapeutics Inc. Equity Warrant2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Why SAB Biotherapeutics Inc. Equity Warrant stock remains undervaluedWeekly Stock Report & Community Consensus Stock Picks - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant reversing from oversold territoryPortfolio Value Report & Real-Time Market Trend Scan - newser.com
Why retail investors pile into SAB Biotherapeutics Inc. stockJuly 2025 Final Week & Capital Protection Trading Alerts - newser.com
Published on: 2025-11-03 03:47:26 - newser.com
Can SAB Biotherapeutics Inc. Equity Warrant stock hit record highs againPortfolio Return Summary & Safe Capital Growth Stock Tips - newser.com
Quantitative breakdown of SAB Biotherapeutics Inc. Equity Warrant recent moveTrade Volume Summary & Growth Focused Stock Reports - newser.com
Real time pattern detection on SAB Biotherapeutics Inc. Equity Warrant stock2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
Why SAB Biotherapeutics Inc. Equity Warrant stock remains on buy listsQuarterly Growth Report & Accurate Trade Setup Notifications - newser.com
Tick level data insight on SAB Biotherapeutics Inc. volatilityJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com
Published on: 2025-11-02 20:28:45 - newser.com
Custom strategy builders for tracking SAB Biotherapeutics Inc.Trade Performance Summary & Verified Swing Trading Watchlists - newser.com
Will SAB Biotherapeutics Inc. rebound enough to break evenPortfolio Profit Report & Verified Swing Trading Watchlists - newser.com
What analysts say about SAB Biotherapeutics Inc stockFlag and Pennant Patterns & Free Daily Stock Hotspot Analysis - earlytimes.in
Using data filters to optimize entry into SAB Biotherapeutics Inc. Equity WarrantLong Setup & Real-Time Buy Signal Notifications - newser.com
Will SAB Biotherapeutics Inc. Equity Warrant stock keep outperforming rivalsCPI Data & Stock Portfolio Risk Management - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant a candidate for recovery play2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com
What hedge fund activity signals for SAB Biotherapeutics Inc. stockShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
How SAB Biotherapeutics Inc. Equity Warrant stock benefits from global expansionWeekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Can SAB Biotherapeutics Inc. Equity Warrant stock resist sector downturns2025 Trading Volume Trends & Long-Term Growth Stock Strategies - newser.com
Will SAB Biotherapeutics Inc. stock maintain dividend yield2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Ranking SAB Biotherapeutics Inc. Equity Warrant among high performing stocks via toolsMarket Activity Summary & Daily Technical Stock Forecast Reports - newser.com
Trend analysis for SAB Biotherapeutics Inc. Equity Warrant this weekWeekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Custom strategy builders for tracking SAB Biotherapeutics Inc. Equity WarrantMarket Performance Report & Free Accurate Trade Setup Notifications - newser.com
Is SAB Biotherapeutics Inc. forming a reversal patternStop Loss & Accurate Trade Setup Notifications - newser.com
Can trapped investors hope for a rebound in SAB Biotherapeutics Inc.Quarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Finanzdaten der Sab Biotherapeutics Inc-Aktie (SABS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sab Biotherapeutics Inc-Aktie (SABS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt | 
|---|---|---|---|---|---|---|---|
| Sessa Capital (Master), L.P. | Director  | 
                        Sep 29 '25  | 
                        Option Exercise  | 
                        1.75  | 
                        1,740,000  | 
                        3,045,000  | 
                        2,198,457  | 
                    
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):